Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC7A5 | Q01650 | 2/20 | 0.50 |
| ▸ | TSHR | P16473 | 2/20 | 0.46 |
| ▸ | SLC1A3 | P43003 | 4/20 | 0.43 |
| ▸ | SLC1A2 | P43004 | 4/20 | 0.43 |
| ▸ | SLC1A1 | P43005 | 4/20 | 0.43 |
| ▸ | CASR | P41180 | 1/20 | 0.38 |
| ▸ | CHRM2 | P08172 | 1/20 | 0.35 |
| ▸ | CHRM4 | P08173 | 1/20 | 0.35 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.35 |
| ▸ | TBXA2R | P21731 | 1/20 | 0.35 |
| ▸ | GALR3 | O60755 | 1/20 | 0.34 |
| ▸ | MAPT | P10636 | 1/20 | 0.34 |
| ▸ | BLM | P54132 | 1/20 | 0.34 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.34 |
| ▸ | TP53 | P04637 | 1/20 | 0.33 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL678144 | 1.00 | SLC7A5 (0.50) | SLC7A5TSHRSLC1A3SLC1A2SLC1A1 | |
| SCHEMBL3449733 | 1.00 | SLC7A5 (0.50) | SLC7A5TSHRSLC1A3SLC1A2SLC1A1 | |
| SCHEMBL22266592 | 0.86 | SLC7A5 (0.46) | SLC7A5TSHRSLC1A3SLC1A2SLC1A1 | |
| SCHEMBL9980804 | 0.84 | NOS3 (0.44) | SLC7A5TSHRSLC1A3SLC1A2SLC1A1 | |
| SCHEMBL420691 | 0.83 | TSHR (0.48) | SLC7A5TSHRSLC1A3SLC1A2SLC1A1 | |
| SCHEMBL28327923 | 0.83 | SLC7A5 (0.52) | SLC7A5SLC1A3SLC1A2SLC1A1CASR | |
| SCHEMBL684104 | 0.83 | TSHR (0.48) | SLC7A5TSHRSLC1A3SLC1A2SLC1A1 | |
| Alanine SCHEMBL15322896 | 0.82 | SLC7A5 (0.35) | SLC7A5TSHRSLC1A3SLC1A2SLC1A1 | |
| SCHEMBL6249367 | 0.82 | SLC7A5 (0.46) | SLC7A5TSHRSLC1A3SLC1A2SLC1A1 | |
| SCHEMBL17351893 | 0.81 | TSHR (0.46) | SLC7A5TSHRCHRM2CHRM4CHRM1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 87 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240418701-A1 | SINGLE MOLECULE IDENTIFICATION WITH A REACTIVE HETERO-NANOPORE | NANJING UNIVERSITY (CN) | 2024-12-19 | — | — | US | claimed |
| EP-4413379-A1 | SINGLE MOLECULE IDENTIFICATION WITH A REACTIVE HETERO-NANOPORE | Nanjing University (CN) | 2024-08-14 | — | — | EP | claimed |
| CN-118103711-A | Single molecule identification with reactive heterogeneous nanopores | 南京大学 | 2024-05-28 | — | — | CN | claimed |
| WO-2023056960-A1 | SINGLE MOLECULE IDENTIFICATION WITH A REACTIVE HETERO-NANOPORE | NANJING UNIVERSITY (CN) | 2023-04-13 | — | — | WO | claimed |
| CN-113788877-A | Novel insect kinin analogs and application thereof in aphid control | 中国农业大学 | 2021-12-14 | — | — | CN | claimed |
| US-9090669-B2 | Short fatty acid tail polymyxin derivatives and uses thereof | NORTHERN ANTIBIOTICS LTD. (FI) | 2015-07-28 | — | — | US | claimed |
| US-8940791-B2 | Acetylated amino acids as anti-platelet agents, nutritional and vitamin supplements | SIGNATURE R&D HOLDINGS, LLC (US) | 2015-01-27 | — | — | US | claimed |
| US-20140200256-A1 | Acetylated amino acids as Anti-platelet agents, Nutritional And Vitamin Supplements | SIGNATURE R&D HOLDINGS, LLC (US) | 2014-07-17 | — | — | US | claimed |
| US-20140142030-A1 | SHORT FATTY ACID TAIL POLYMYXIN DERIVATIVES AND USES THEREOF | NORTHERN ANTIBIOTICS LTD. (FI) | 2014-05-22 | — | — | US | claimed |
| US-8642535-B2 | Short fatty acid tail polymyxin derivatives and uses thereof | NORTHERN ANTIBIOTICS LTD. (FI) | 2014-02-04 | — | — | US | claimed |
| US-20120283176-A1 | SHORT FATTY ACID TAIL POLYMYXIN DERIVATIVES AND USES THEREOF | NORTHERN ANTIBIOTICS LTD. (FI) | 2012-11-08 | — | — | US | claimed |
| US-8003683-B2 | Acetylated amino acids as anti-platelet agents, nutritional and vitamin supplements | SIGNATURE R&D HOLDINGS, LLC (US) | 2011-08-23 | — | — | US | claimed |
| US-20070112060-A1 | Acetylated amino acids as anti-platelet agents, nutritional and vitamin supplements | SIGNATURE R&D HOLDINGS, LLC | 2007-05-17 | — | — | US | claimed |
| US-20260125418-A1 | A COMPOUND AND ITS USE FOR DETECTING A DISEASE IN THE EXHALED BREATH OF A SUBJECT | OWLSTONE MED LTD (GB) | 2026-05-07 | — | — | US | disclosed |
| US-20260034237-A1 | LINKERS, DRUG LINKERS AND CONJUGATES THEREOF AND METHODS OF USING THE SAME | GENMAB AS (DK) | 2026-02-05 | — | — | US | disclosed |
| EP-4598592-A1 | A COMPOUND AND ITS USE FOR DETECTING A DISEASE IN THE EXHALED BREATH OF A SUBJECT | Owlstone Medical Limited (GB) | 2025-08-13 | — | — | EP | disclosed |
| EP-0626174-A2 | Methods and compositions for the prophylactic and/or therapeutic treatment of organ hypofunction | TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) | 1994-11-30 | — | — | EP | disclosed |
| EP-0552417-A1 | Cyclic peptides and use thereof | TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) | 1993-07-28 | — | — | EP | disclosed |
| EP-0528312-A2 | Cyclic peptides and use thereof | TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) | 1993-02-24 | — | — | EP | disclosed |
| US-4740611-A | N,N'-disubstituted ureas | THE STANDARD OIL COMPANY (US) | 1988-04-26 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260034237-A1 | LINKERS, DRUG LINKERS AND CONJUGATES THEREOF AND METHODS OF USING THE SAME | CSGALNACT1, SLC43A1, OSTC | SLC7A5 54/4885TSHR 389/4885SLC1A3 46/4885 |
| US-20260125418-A1 | A COMPOUND AND ITS USE FOR DETECTING A DISEASE IN THE EXHALED BREATH OF A SUBJECT | BRCA1, L3MBTL1, LMNA | SLC7A5 1833/4885TSHR 2719/4885SLC1A3 3087/4885 |
| US-20140200256-A1 | Acetylated amino acids as Anti-platelet agents, Nutritional And Vitamin Supplements | PLTP, GP6, PDGFA | SLC7A5 500/4885TSHR 3362/4885SLC1A3 591/4885 |
| US-20070112060-A1 | Acetylated amino acids as anti-platelet agents, nutritional and vitamin supplements | PLTP, GP6, PDGFA | SLC7A5 500/4885TSHR 3362/4885SLC1A3 591/4885 |
| US-20140142030-A1 | SHORT FATTY ACID TAIL POLYMYXIN DERIVATIVES AND USES THEREOF | VIP, ELOVL5, TLR5 | SLC7A5 178/4885TSHR 4653/4885SLC1A3 4004/4885 |
| US-20120283176-A1 | SHORT FATTY ACID TAIL POLYMYXIN DERIVATIVES AND USES THEREOF | ELOVL5, TLR5, VIP | SLC7A5 179/4885TSHR 4693/4885SLC1A3 3910/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.